

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.45579929 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.08020441 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.71536276 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.70376446 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 5.67227860 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.59937221 |
| 7 | vocalization behavior (GO:0071625) | 5.59386707 |
| 8 | glutamate secretion (GO:0014047) | 5.28342936 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.25071893 |
| 10 | protein localization to synapse (GO:0035418) | 5.13758705 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.13194040 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.94341973 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.89129989 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.78541988 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.65181275 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.61958943 |
| 17 | L-amino acid import (GO:0043092) | 4.59722719 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.55746024 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 4.55585329 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.49862403 |
| 21 | exploration behavior (GO:0035640) | 4.41885919 |
| 22 | glutamate receptor signaling pathway (GO:0007215) | 4.33821002 |
| 23 | gamma-aminobutyric acid transport (GO:0015812) | 4.30680370 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.27606423 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.26502793 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.26050146 |
| 27 | sodium ion export (GO:0071436) | 4.24036456 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 4.23750365 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.21427581 |
| 30 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.18219082 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 4.14274199 |
| 32 | amino acid import (GO:0043090) | 4.13327752 |
| 33 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.08732676 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 3.96314624 |
| 35 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.95934856 |
| 36 | regulation of synapse structural plasticity (GO:0051823) | 3.93163845 |
| 37 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.91335043 |
| 38 | neurotransmitter transport (GO:0006836) | 3.89438750 |
| 39 | neuronal ion channel clustering (GO:0045161) | 3.89337966 |
| 40 | long-term memory (GO:0007616) | 3.88797537 |
| 41 | positive regulation of membrane potential (GO:0045838) | 3.87513667 |
| 42 | positive regulation of dendritic spine development (GO:0060999) | 3.86720117 |
| 43 | regulation of synapse maturation (GO:0090128) | 3.83970504 |
| 44 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.83736963 |
| 45 | proline transport (GO:0015824) | 3.83252427 |
| 46 | dendritic spine morphogenesis (GO:0060997) | 3.72278011 |
| 47 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.71588649 |
| 48 | regulation of postsynaptic membrane potential (GO:0060078) | 3.70182096 |
| 49 | synaptic vesicle endocytosis (GO:0048488) | 3.70021295 |
| 50 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.68245542 |
| 51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.66609883 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.66590849 |
| 53 | central nervous system myelination (GO:0022010) | 3.66544117 |
| 54 | axon ensheathment in central nervous system (GO:0032291) | 3.66544117 |
| 55 | cellular sodium ion homeostasis (GO:0006883) | 3.65569523 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.61787546 |
| 57 | positive regulation of neurotransmitter transport (GO:0051590) | 3.55953035 |
| 58 | neuromuscular process controlling posture (GO:0050884) | 3.55872043 |
| 59 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.55647599 |
| 60 | long-term synaptic potentiation (GO:0060291) | 3.53498621 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.53344439 |
| 62 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.52339533 |
| 63 | regulation of neurotransmitter levels (GO:0001505) | 3.50921043 |
| 64 | transmission of nerve impulse (GO:0019226) | 3.48551178 |
| 65 | regulation of synaptic plasticity (GO:0048167) | 3.48007996 |
| 66 | dendritic spine organization (GO:0097061) | 3.45061238 |
| 67 | neuron recognition (GO:0008038) | 3.44138430 |
| 68 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.41057771 |
| 69 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.39455948 |
| 70 | membrane hyperpolarization (GO:0060081) | 3.38150765 |
| 71 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.37190983 |
| 72 | cell communication by electrical coupling (GO:0010644) | 3.36854328 |
| 73 | activation of protein kinase A activity (GO:0034199) | 3.36618302 |
| 74 | regulation of neurotransmitter transport (GO:0051588) | 3.36451629 |
| 75 | presynaptic membrane assembly (GO:0097105) | 3.36380547 |
| 76 | presynaptic membrane organization (GO:0097090) | 3.35800979 |
| 77 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.34500876 |
| 78 | response to histamine (GO:0034776) | 3.34218578 |
| 79 | neuromuscular process controlling balance (GO:0050885) | 3.33409181 |
| 80 | postsynaptic membrane organization (GO:0001941) | 3.33216778 |
| 81 | glycine transport (GO:0015816) | 3.32862106 |
| 82 | regulation of vesicle fusion (GO:0031338) | 3.31899270 |
| 83 | regulation of ARF protein signal transduction (GO:0032012) | 3.30115864 |
| 84 | regulation of dendritic spine development (GO:0060998) | 3.28935680 |
| 85 | membrane depolarization during action potential (GO:0086010) | 3.27458336 |
| 86 | chemosensory behavior (GO:0007635) | 3.25552891 |
| 87 | cell differentiation in hindbrain (GO:0021533) | 3.24674892 |
| 88 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.24434871 |
| 89 | response to auditory stimulus (GO:0010996) | 3.24230552 |
| 90 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.22828562 |
| 91 | membrane depolarization (GO:0051899) | 3.22237366 |
| 92 | synaptic vesicle transport (GO:0048489) | 3.19211658 |
| 93 | establishment of synaptic vesicle localization (GO:0097480) | 3.19211658 |
| 94 | auditory behavior (GO:0031223) | 3.19106489 |
| 95 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.18369413 |
| 96 | cerebellar granule cell differentiation (GO:0021707) | 3.16772976 |
| 97 | acidic amino acid transport (GO:0015800) | 3.15480326 |
| 98 | behavioral defense response (GO:0002209) | 3.14335419 |
| 99 | behavioral fear response (GO:0001662) | 3.14335419 |
| 100 | axonal fasciculation (GO:0007413) | 3.13490002 |
| 101 | positive regulation of synaptic transmission (GO:0050806) | 3.12581701 |
| 102 | potassium ion homeostasis (GO:0055075) | 3.12527839 |
| 103 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.11810965 |
| 104 | prepulse inhibition (GO:0060134) | 3.10775204 |
| 105 | innervation (GO:0060384) | 3.10631416 |
| 106 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.09377838 |
| 107 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.09267975 |
| 108 | cell communication involved in cardiac conduction (GO:0086065) | 3.07502065 |
| 109 | learning (GO:0007612) | 3.06939171 |
| 110 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05807300 |
| 111 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.05551856 |
| 112 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.05070108 |
| 113 | social behavior (GO:0035176) | 3.05000150 |
| 114 | intraspecies interaction between organisms (GO:0051703) | 3.05000150 |
| 115 | synaptic transmission (GO:0007268) | 3.04842596 |
| 116 | neuromuscular process (GO:0050905) | 3.04525201 |
| 117 | synapse assembly (GO:0007416) | 3.02602095 |
| 118 | potassium ion import (GO:0010107) | 3.01295531 |
| 119 | mating behavior (GO:0007617) | 3.01144730 |
| 120 | regulation of synaptic transmission (GO:0050804) | 3.00917179 |
| 121 | phosphorelay signal transduction system (GO:0000160) | 3.00568864 |
| 122 | neuromuscular synaptic transmission (GO:0007274) | 3.00457020 |
| 123 | adult walking behavior (GO:0007628) | 2.99638286 |
| 124 | fear response (GO:0042596) | 2.99085231 |
| 125 | behavioral response to cocaine (GO:0048148) | 2.99007611 |
| 126 | dendrite morphogenesis (GO:0048813) | 2.97864947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.95013314 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.54567755 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.27480053 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.16060796 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16053802 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.05635884 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.81331561 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74575474 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.73938339 |
| 10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.73938339 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.64373496 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.63649908 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.62638255 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.62341250 |
| 15 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58547402 |
| 16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.55762146 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50615718 |
| 18 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45408852 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.38419358 |
| 20 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.35742644 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.34201426 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32877767 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.31832196 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.26841395 |
| 25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.22628208 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20358184 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.14736444 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.05137579 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01678954 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99770594 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.98947839 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.84560745 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.77705423 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69063467 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67281999 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61381304 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.51638869 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48978376 |
| 39 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41868364 |
| 40 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.39488406 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.37650803 |
| 42 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.34704788 |
| 43 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33571913 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30470984 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30336650 |
| 46 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.30143880 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29480926 |
| 48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27477313 |
| 49 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.26505385 |
| 50 | AR_19668381_ChIP-Seq_PC3_Human | 1.26064842 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25963300 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25610424 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25111764 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23057184 |
| 55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22407427 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21328354 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20409097 |
| 58 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.20004954 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16146071 |
| 60 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15747041 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15136918 |
| 62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.15068237 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14719145 |
| 64 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14032374 |
| 65 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13174879 |
| 66 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.11260659 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10821282 |
| 68 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07536736 |
| 69 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.07159334 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07059625 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06295765 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06261478 |
| 73 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05886902 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04185940 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04055779 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03917764 |
| 77 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.02971958 |
| 78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01732558 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01163815 |
| 80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00540726 |
| 81 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00318671 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99974537 |
| 83 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99476557 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99144421 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97898989 |
| 86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96634660 |
| 87 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95601239 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95597810 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94844791 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94144051 |
| 91 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.93412332 |
| 92 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.92924683 |
| 93 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92668594 |
| 94 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92225506 |
| 95 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90955734 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90805327 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90196359 |
| 98 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90143010 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90094799 |
| 100 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.89843995 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89842478 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89234947 |
| 103 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.88947071 |
| 104 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88924720 |
| 105 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.86758115 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86550367 |
| 107 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.86032273 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85709817 |
| 109 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.85684110 |
| 110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85483501 |
| 111 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.85440598 |
| 112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84624978 |
| 113 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.84174257 |
| 114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83800582 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83767392 |
| 116 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83380233 |
| 117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83106257 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82808304 |
| 119 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.82694984 |
| 120 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82591572 |
| 121 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.82591572 |
| 122 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.82357618 |
| 123 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81811179 |
| 124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79671950 |
| 125 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76642103 |
| 126 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75764310 |
| 127 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.71806777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.19672437 |
| 2 | MP0003880_abnormal_central_pattern | 4.78618470 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.09717607 |
| 4 | MP0004270_analgesia | 3.54003898 |
| 5 | MP0009745_abnormal_behavioral_response | 3.36815500 |
| 6 | MP0009046_muscle_twitch | 3.35860495 |
| 7 | MP0005423_abnormal_somatic_nervous | 3.34108082 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.23075396 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.20175394 |
| 10 | MP0002064_seizures | 3.18878744 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.76252508 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.69649493 |
| 13 | MP0002272_abnormal_nervous_system | 2.67306538 |
| 14 | MP0002822_catalepsy | 2.63631330 |
| 15 | MP0002736_abnormal_nociception_after | 2.55666254 |
| 16 | MP0001486_abnormal_startle_reflex | 2.51655940 |
| 17 | MP0005551_abnormal_eye_electrophysiolog | 2.46157520 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.31411032 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.24778115 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.07655471 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.05792573 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.00146814 |
| 23 | MP0008569_lethality_at_weaning | 1.99331632 |
| 24 | MP0001970_abnormal_pain_threshold | 1.95264730 |
| 25 | MP0001984_abnormal_olfaction | 1.81515130 |
| 26 | MP0002184_abnormal_innervation | 1.80938820 |
| 27 | MP0003329_amyloid_beta_deposits | 1.80720726 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.77571644 |
| 29 | MP0004924_abnormal_behavior | 1.76157318 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.76157318 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.73923766 |
| 32 | MP0004858_abnormal_nervous_system | 1.67806650 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.65781709 |
| 34 | MP0000778_abnormal_nervous_system | 1.63697624 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.60567096 |
| 36 | MP0001529_abnormal_vocalization | 1.59207007 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.57709256 |
| 38 | MP0002882_abnormal_neuron_morphology | 1.57134009 |
| 39 | MP0003879_abnormal_hair_cell | 1.55542688 |
| 40 | MP0000955_abnormal_spinal_cord | 1.50532109 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.48973676 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.46630913 |
| 43 | MP0004885_abnormal_endolymph | 1.45332907 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.41147198 |
| 45 | MP0002229_neurodegeneration | 1.40502681 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.38717844 |
| 47 | MP0004142_abnormal_muscle_tone | 1.38278293 |
| 48 | MP0000579_abnormal_nail_morphology | 1.37093269 |
| 49 | MP0001346_abnormal_lacrimal_gland | 1.36127217 |
| 50 | MP0005253_abnormal_eye_physiology | 1.35360104 |
| 51 | MP0003787_abnormal_imprinting | 1.34960639 |
| 52 | MP0004147_increased_porphyrin_level | 1.33463190 |
| 53 | MP0003122_maternal_imprinting | 1.29755612 |
| 54 | MP0003633_abnormal_nervous_system | 1.27544580 |
| 55 | MP0008872_abnormal_physiological_respon | 1.20532721 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.17611111 |
| 57 | MP0001905_abnormal_dopamine_level | 1.17499651 |
| 58 | MP0002090_abnormal_vision | 1.14807503 |
| 59 | MP0005645_abnormal_hypothalamus_physiol | 1.14327173 |
| 60 | MP0003123_paternal_imprinting | 1.13711759 |
| 61 | MP0005623_abnormal_meninges_morphology | 1.11044889 |
| 62 | MP0003631_nervous_system_phenotype | 1.10266449 |
| 63 | MP0002152_abnormal_brain_morphology | 1.09007630 |
| 64 | MP0005499_abnormal_olfactory_system | 1.07654971 |
| 65 | MP0005394_taste/olfaction_phenotype | 1.07654971 |
| 66 | MP0002638_abnormal_pupillary_reflex | 1.06444726 |
| 67 | MP0002752_abnormal_somatic_nervous | 1.02717480 |
| 68 | MP0000751_myopathy | 1.01614154 |
| 69 | MP0004215_abnormal_myocardial_fiber | 0.97992502 |
| 70 | MP0001188_hyperpigmentation | 0.97242409 |
| 71 | MP0000566_synostosis | 0.95279189 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 0.93739167 |
| 73 | MP0002234_abnormal_pharynx_morphology | 0.93673129 |
| 74 | MP0003634_abnormal_glial_cell | 0.92081312 |
| 75 | MP0001348_abnormal_lacrimal_gland | 0.90836261 |
| 76 | MP0002069_abnormal_eating/drinking_beha | 0.90232232 |
| 77 | MP0004742_abnormal_vestibular_system | 0.89425322 |
| 78 | MP0004233_abnormal_muscle_weight | 0.87344929 |
| 79 | MP0002653_abnormal_ependyma_morphology | 0.84413415 |
| 80 | MP0004085_abnormal_heartbeat | 0.84144733 |
| 81 | MP0005195_abnormal_posterior_eye | 0.82156034 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.81681295 |
| 83 | MP0003632_abnormal_nervous_system | 0.80969633 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.78044672 |
| 85 | MP0008874_decreased_physiological_sensi | 0.77503002 |
| 86 | MP0001299_abnormal_eye_distance/ | 0.75901129 |
| 87 | MP0003011_delayed_dark_adaptation | 0.75703386 |
| 88 | MP0008877_abnormal_DNA_methylation | 0.75124460 |
| 89 | MP0003075_altered_response_to | 0.74081648 |
| 90 | MP0005535_abnormal_body_temperature | 0.74075865 |
| 91 | MP0000604_amyloidosis | 0.73881173 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.72786529 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.71940759 |
| 94 | MP0003690_abnormal_glial_cell | 0.70675227 |
| 95 | MP0001177_atelectasis | 0.69994074 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.68423246 |
| 97 | MP0000920_abnormal_myelination | 0.67708276 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.65632100 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.65605531 |
| 100 | MP0001986_abnormal_taste_sensitivity | 0.63783883 |
| 101 | MP0003283_abnormal_digestive_organ | 0.63748474 |
| 102 | MP0000026_abnormal_inner_ear | 0.63558828 |
| 103 | MP0004043_abnormal_pH_regulation | 0.61554283 |
| 104 | MP0002249_abnormal_larynx_morphology | 0.60275694 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.57967918 |
| 106 | MP0010769_abnormal_survival | 0.55748111 |
| 107 | MP0004484_altered_response_of | 0.54522263 |
| 108 | MP0002837_dystrophic_cardiac_calcinosis | 0.54233809 |
| 109 | MP0002082_postnatal_lethality | 0.53266536 |
| 110 | MP0010770_preweaning_lethality | 0.53266536 |
| 111 | MP0001943_abnormal_respiration | 0.52860077 |
| 112 | MP0010768_mortality/aging | 0.52661652 |
| 113 | MP0003646_muscle_fatigue | 0.52605845 |
| 114 | MP0003861_abnormal_nervous_system | 0.52583150 |
| 115 | MP0003121_genomic_imprinting | 0.52222596 |
| 116 | MP0010030_abnormal_orbit_morphology | 0.50795749 |
| 117 | MP0005187_abnormal_penis_morphology | 0.49756650 |
| 118 | MP0005171_absent_coat_pigmentation | 0.49119965 |
| 119 | MP0003938_abnormal_ear_development | 0.47845993 |
| 120 | MP0003956_abnormal_body_size | 0.46863866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.11730707 |
| 2 | Myokymia (HP:0002411) | 6.30860508 |
| 3 | Focal seizures (HP:0007359) | 5.41905329 |
| 4 | Visual hallucinations (HP:0002367) | 5.17323191 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.96206273 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.62967050 |
| 7 | Febrile seizures (HP:0002373) | 4.44855521 |
| 8 | Atonic seizures (HP:0010819) | 4.37310957 |
| 9 | Congenital stationary night blindness (HP:0007642) | 4.29045537 |
| 10 | Absence seizures (HP:0002121) | 4.05521506 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.86251721 |
| 12 | Action tremor (HP:0002345) | 3.84088631 |
| 13 | Dialeptic seizures (HP:0011146) | 3.68328589 |
| 14 | Dysdiadochokinesis (HP:0002075) | 3.54727579 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.50479452 |
| 16 | Broad-based gait (HP:0002136) | 3.46636270 |
| 17 | Depression (HP:0000716) | 3.42265824 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.38772741 |
| 19 | Central scotoma (HP:0000603) | 3.34660111 |
| 20 | Truncal ataxia (HP:0002078) | 3.29874225 |
| 21 | Tetraplegia (HP:0002445) | 3.22725964 |
| 22 | Poor eye contact (HP:0000817) | 3.22642832 |
| 23 | Ankle clonus (HP:0011448) | 3.19901079 |
| 24 | Mutism (HP:0002300) | 3.12944539 |
| 25 | Abnormality of macular pigmentation (HP:0008002) | 3.11022626 |
| 26 | Anxiety (HP:0000739) | 3.08714092 |
| 27 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.03015737 |
| 28 | Impaired social interactions (HP:0000735) | 3.02893671 |
| 29 | Abnormal social behavior (HP:0012433) | 3.02893671 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.00594109 |
| 31 | Dysmetria (HP:0001310) | 2.91951588 |
| 32 | Postural instability (HP:0002172) | 2.91402711 |
| 33 | Genetic anticipation (HP:0003743) | 2.86895488 |
| 34 | Hyperventilation (HP:0002883) | 2.86127141 |
| 35 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.85115313 |
| 36 | Abnormal eating behavior (HP:0100738) | 2.83520106 |
| 37 | Cerebral hypomyelination (HP:0006808) | 2.82040729 |
| 38 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.78642466 |
| 39 | Hemiparesis (HP:0001269) | 2.75646903 |
| 40 | Abnormality of binocular vision (HP:0011514) | 2.73279704 |
| 41 | Diplopia (HP:0000651) | 2.73279704 |
| 42 | Impaired smooth pursuit (HP:0007772) | 2.69971113 |
| 43 | Insomnia (HP:0100785) | 2.68581688 |
| 44 | Obstructive sleep apnea (HP:0002870) | 2.67175433 |
| 45 | Progressive inability to walk (HP:0002505) | 2.66108868 |
| 46 | Hemiplegia (HP:0002301) | 2.63385227 |
| 47 | Bradykinesia (HP:0002067) | 2.60124109 |
| 48 | Scotoma (HP:0000575) | 2.58779367 |
| 49 | Abnormality of the lower motor neuron (HP:0002366) | 2.55291287 |
| 50 | Amblyopia (HP:0000646) | 2.55121321 |
| 51 | Dysmetric saccades (HP:0000641) | 2.52982246 |
| 52 | Scanning speech (HP:0002168) | 2.51375645 |
| 53 | Clonus (HP:0002169) | 2.50664592 |
| 54 | Excessive salivation (HP:0003781) | 2.50643008 |
| 55 | Drooling (HP:0002307) | 2.50643008 |
| 56 | Akinesia (HP:0002304) | 2.45687361 |
| 57 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.44850352 |
| 58 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.44467274 |
| 59 | Spastic gait (HP:0002064) | 2.43490877 |
| 60 | Torticollis (HP:0000473) | 2.41695615 |
| 61 | Status epilepticus (HP:0002133) | 2.36330549 |
| 62 | Urinary urgency (HP:0000012) | 2.35894302 |
| 63 | Apathy (HP:0000741) | 2.35770236 |
| 64 | Intention tremor (HP:0002080) | 2.35245751 |
| 65 | Papilledema (HP:0001085) | 2.35178518 |
| 66 | Epileptiform EEG discharges (HP:0011182) | 2.31825048 |
| 67 | Absent speech (HP:0001344) | 2.30728957 |
| 68 | Gait imbalance (HP:0002141) | 2.28356966 |
| 69 | Delusions (HP:0000746) | 2.27457227 |
| 70 | Focal dystonia (HP:0004373) | 2.26091676 |
| 71 | Turricephaly (HP:0000262) | 2.25693430 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.24942059 |
| 73 | Ventricular fibrillation (HP:0001663) | 2.22227290 |
| 74 | Rigidity (HP:0002063) | 2.21617559 |
| 75 | Polyphagia (HP:0002591) | 2.19599155 |
| 76 | Limb dystonia (HP:0002451) | 2.19286491 |
| 77 | Impaired vibratory sensation (HP:0002495) | 2.18804959 |
| 78 | Pheochromocytoma (HP:0002666) | 2.18136334 |
| 79 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.18049370 |
| 80 | Cerebral inclusion bodies (HP:0100314) | 2.17458993 |
| 81 | Stereotypic behavior (HP:0000733) | 2.13860654 |
| 82 | Inability to walk (HP:0002540) | 2.13491814 |
| 83 | Neurofibrillary tangles (HP:0002185) | 2.12972123 |
| 84 | Severe visual impairment (HP:0001141) | 2.12645075 |
| 85 | Decreased central vision (HP:0007663) | 2.12354678 |
| 86 | Generalized myoclonic seizures (HP:0002123) | 2.10696229 |
| 87 | Dyschromatopsia (HP:0007641) | 2.10020286 |
| 88 | Hypsarrhythmia (HP:0002521) | 2.09613926 |
| 89 | Megalencephaly (HP:0001355) | 2.06240805 |
| 90 | Spastic tetraparesis (HP:0001285) | 2.04428922 |
| 91 | Diminished motivation (HP:0000745) | 2.04308172 |
| 92 | Split foot (HP:0001839) | 2.03873259 |
| 93 | Choreoathetosis (HP:0001266) | 2.03708287 |
| 94 | Craniofacial dystonia (HP:0012179) | 2.01654010 |
| 95 | Bundle branch block (HP:0011710) | 2.00008424 |
| 96 | Sleep apnea (HP:0010535) | 1.99488700 |
| 97 | Lower limb muscle weakness (HP:0007340) | 1.99132852 |
| 98 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.98679629 |
| 99 | Abnormality of the corticospinal tract (HP:0002492) | 1.98293581 |
| 100 | Peripheral hypomyelination (HP:0007182) | 1.97790392 |
| 101 | Neuroendocrine neoplasm (HP:0100634) | 1.94469316 |
| 102 | Psychosis (HP:0000709) | 1.94333576 |
| 103 | Specific learning disability (HP:0001328) | 1.90923389 |
| 104 | Choroideremia (HP:0001139) | 1.89745009 |
| 105 | Annular pancreas (HP:0001734) | 1.89516976 |
| 106 | Neuronal loss in central nervous system (HP:0002529) | 1.89254725 |
| 107 | Termporal pattern (HP:0011008) | 1.88748433 |
| 108 | Insidious onset (HP:0003587) | 1.88748433 |
| 109 | Poikilocytosis (HP:0004447) | 1.88346585 |
| 110 | Congenital primary aphakia (HP:0007707) | 1.88330064 |
| 111 | Hypoventilation (HP:0002791) | 1.88013235 |
| 112 | Fetal akinesia sequence (HP:0001989) | 1.87226993 |
| 113 | Protruding tongue (HP:0010808) | 1.87045825 |
| 114 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.86887811 |
| 115 | Aplasia of the phalanges of the hand (HP:0009802) | 1.86887811 |
| 116 | Aplasia involving bones of the extremities (HP:0009825) | 1.86887811 |
| 117 | Lower limb asymmetry (HP:0100559) | 1.86638429 |
| 118 | Incomplete penetrance (HP:0003829) | 1.86615246 |
| 119 | Gait ataxia (HP:0002066) | 1.86009717 |
| 120 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.85161016 |
| 121 | Abnormality of saccadic eye movements (HP:0000570) | 1.85053542 |
| 122 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.80350803 |
| 123 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.80350803 |
| 124 | Rapidly progressive (HP:0003678) | 1.78351386 |
| 125 | CNS hypomyelination (HP:0003429) | 1.78298175 |
| 126 | Amyotrophic lateral sclerosis (HP:0007354) | 1.71432082 |
| 127 | Prolonged QT interval (HP:0001657) | 1.67839681 |
| 128 | Pointed chin (HP:0000307) | 1.62588752 |
| 129 | Unsteady gait (HP:0002317) | 1.61538050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.46786635 |
| 2 | EPHA4 | 4.23463446 |
| 3 | MAP3K9 | 3.88893176 |
| 4 | MAP3K4 | 3.30898573 |
| 5 | MARK1 | 3.10736442 |
| 6 | MINK1 | 2.86283813 |
| 7 | MAP2K7 | 2.78844359 |
| 8 | DAPK2 | 2.44952955 |
| 9 | PAK6 | 2.31335011 |
| 10 | NTRK2 | 2.15908784 |
| 11 | MAP3K12 | 2.06733498 |
| 12 | MAP2K4 | 1.98187761 |
| 13 | CASK | 1.93669644 |
| 14 | KSR2 | 1.88983575 |
| 15 | CAMKK1 | 1.79852487 |
| 16 | NTRK1 | 1.71878311 |
| 17 | PRKD3 | 1.68843453 |
| 18 | SIK2 | 1.63348889 |
| 19 | CDK5 | 1.59688883 |
| 20 | TNIK | 1.57336820 |
| 21 | KSR1 | 1.56516085 |
| 22 | RIPK4 | 1.53163911 |
| 23 | GRK5 | 1.50385192 |
| 24 | DAPK1 | 1.47712502 |
| 25 | MAPK13 | 1.43110642 |
| 26 | PLK2 | 1.39923019 |
| 27 | CDK19 | 1.36012894 |
| 28 | STK38 | 1.35391658 |
| 29 | PNCK | 1.33924595 |
| 30 | PRKCG | 1.31347818 |
| 31 | CAMKK2 | 1.24607854 |
| 32 | NEK6 | 1.17675166 |
| 33 | PRPF4B | 1.16143278 |
| 34 | UHMK1 | 1.14148359 |
| 35 | PHKG2 | 1.13901754 |
| 36 | PHKG1 | 1.13901754 |
| 37 | IRAK2 | 1.13164711 |
| 38 | ARAF | 1.12854884 |
| 39 | SGK223 | 1.11190745 |
| 40 | SGK494 | 1.11190745 |
| 41 | TAOK1 | 1.07047997 |
| 42 | FES | 1.06628248 |
| 43 | CDK18 | 1.04692952 |
| 44 | CDK15 | 1.01405831 |
| 45 | CDK14 | 0.96170257 |
| 46 | CAMK1 | 0.92703048 |
| 47 | CAMK2A | 0.91584888 |
| 48 | SGK2 | 0.91514320 |
| 49 | PINK1 | 0.91432819 |
| 50 | PRKCH | 0.90451013 |
| 51 | NEK1 | 0.90348256 |
| 52 | CDK11A | 0.89544741 |
| 53 | TNK2 | 0.86252095 |
| 54 | DYRK1A | 0.85689841 |
| 55 | MAP3K13 | 0.84319570 |
| 56 | CCNB1 | 0.81387234 |
| 57 | MAP3K2 | 0.81187999 |
| 58 | FGFR2 | 0.80821377 |
| 59 | STK11 | 0.79439292 |
| 60 | LMTK2 | 0.78473475 |
| 61 | TYRO3 | 0.77601401 |
| 62 | SGK3 | 0.77128331 |
| 63 | LATS2 | 0.74473704 |
| 64 | SGK1 | 0.73884740 |
| 65 | RET | 0.72251788 |
| 66 | PKN1 | 0.69570872 |
| 67 | ALK | 0.69431144 |
| 68 | CAMK1G | 0.68771532 |
| 69 | CAMK2B | 0.66412941 |
| 70 | NME1 | 0.65070538 |
| 71 | BRSK1 | 0.63960920 |
| 72 | RAF1 | 0.63943394 |
| 73 | LIMK1 | 0.62964274 |
| 74 | AKT3 | 0.61379451 |
| 75 | SIK3 | 0.61378159 |
| 76 | DAPK3 | 0.61157176 |
| 77 | PTK2B | 0.60806872 |
| 78 | PAK3 | 0.58827960 |
| 79 | SCYL2 | 0.58716425 |
| 80 | MAPK12 | 0.57798572 |
| 81 | RPS6KA3 | 0.56728615 |
| 82 | TESK1 | 0.55401824 |
| 83 | CDC42BPA | 0.55136691 |
| 84 | PRKCZ | 0.54488371 |
| 85 | CSNK1G2 | 0.53966314 |
| 86 | WNK1 | 0.53090124 |
| 87 | PDK1 | 0.52452725 |
| 88 | OXSR1 | 0.52152376 |
| 89 | MARK2 | 0.49958825 |
| 90 | PRKG2 | 0.47891001 |
| 91 | MAPK10 | 0.47840005 |
| 92 | PDPK1 | 0.47288167 |
| 93 | MAP3K11 | 0.46784570 |
| 94 | ROCK2 | 0.46620294 |
| 95 | MAP3K1 | 0.46138774 |
| 96 | CAMK2D | 0.45196901 |
| 97 | CAMK4 | 0.44403876 |
| 98 | RIPK1 | 0.41686352 |
| 99 | GRK1 | 0.41379377 |
| 100 | PRKCB | 0.41203730 |
| 101 | PRKCE | 0.41045046 |
| 102 | MOS | 0.39305976 |
| 103 | MAP2K1 | 0.39112938 |
| 104 | ADRBK1 | 0.38825780 |
| 105 | FYN | 0.36997099 |
| 106 | BMPR2 | 0.36746337 |
| 107 | CAMK2G | 0.36510735 |
| 108 | MAPKAPK5 | 0.36402552 |
| 109 | ERBB2 | 0.35983684 |
| 110 | MUSK | 0.34966009 |
| 111 | BRAF | 0.34917539 |
| 112 | PRKACA | 0.31829704 |
| 113 | PRKCA | 0.30935936 |
| 114 | ICK | 0.30712594 |
| 115 | CSNK1D | 0.30098381 |
| 116 | PRKG1 | 0.29602926 |
| 117 | MAPK8 | 0.25841387 |
| 118 | SRC | 0.23993522 |
| 119 | RPS6KB1 | 0.23395553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.98970557 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.72713468 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.21012108 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.97203084 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.79906111 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.77750954 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.68720028 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.62847567 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.60684993 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.50342752 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.32062752 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.25305093 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.18833822 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.15107238 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.98222697 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.87769784 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.82375319 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.78421872 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.76495242 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.76014066 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64633237 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62762891 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.61892919 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.60075592 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.57735948 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55743293 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52638807 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.52389977 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.38522498 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32522426 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.30371467 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.27864799 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20899587 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20269422 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.16400002 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13186963 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08959316 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07685560 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05897462 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01435758 |
| 41 | Glioma_Homo sapiens_hsa05214 | 1.00902638 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00210741 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98303170 |
| 44 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97010166 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96576569 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 0.94728185 |
| 47 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90468868 |
| 48 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88992621 |
| 49 | Alcoholism_Homo sapiens_hsa05034 | 0.87786993 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 0.86552732 |
| 51 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82849058 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80395791 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76110995 |
| 54 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75873131 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.73687533 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72732445 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71389480 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70426109 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66502376 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66031000 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62598092 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62196171 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60876212 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60069306 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59000275 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55206611 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54364523 |
| 68 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52868733 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.51101801 |
| 70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50670206 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50421079 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49701299 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49240010 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47340638 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47130859 |
| 76 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46907505 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46027444 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45465386 |
| 79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45176061 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44717868 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.43802146 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41021079 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39777603 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39437421 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38118434 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37712728 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36927039 |
| 88 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36316404 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36311231 |
| 90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.36296565 |
| 91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36007158 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35744244 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34328554 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34076396 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32710847 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32482648 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31720390 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.31353533 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30125887 |
| 100 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27603576 |
| 101 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27366937 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25531291 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.25228040 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.25114923 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24364820 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.23336631 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.22785346 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.22596621 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22274636 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.18052006 |

